U#3888_MH_ResearchReport (S)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Monash Health<br />
Message from the Chair of the Board<br />
and the Chief Executive<br />
We are delighted to present the 2017 Monash Health Translational Precinct (<strong>MH</strong>TP)<br />
Research Report. The report highlights the outstanding achievements of Monash<br />
Health’s researchers and clinicians, together with our <strong>MH</strong>TP partners.<br />
This was a remarkable year for <strong>MH</strong>TP,<br />
with 1171 active research projects<br />
under way. From world-first oncology<br />
trials such as those lead by Dr Ben<br />
Markman and a world-first study in<br />
pre-term infants led by Professor Euan<br />
Wallace – our research offers hope<br />
to many patients and families facing<br />
seriou illness.<br />
The title of this report reflects our<br />
commitment to collaborative research<br />
with our key research partners, the<br />
Hudson Institute of Medical Research<br />
and Monash University.<br />
Clinical trials are a major component of<br />
Monash Health’s research profile and<br />
present an opportunity for consumers<br />
to access the latest technology,<br />
advancements and access to increased<br />
resources in terms of monitoring,<br />
follow up and positive lifestyle<br />
interventions. This is facilitated<br />
through the state-of-the-art Monash<br />
Health Clinical Trials Centre, which<br />
opened in December 2015.<br />
The calibre of our work has been<br />
acknowledged by our funding success,<br />
with more than $15.3 million in<br />
National Health and Medical Research<br />
Council of Australia (NHMRC) funding<br />
awarded to Monash Health and our<br />
<strong>MH</strong>TP partners in 2017. In addition,<br />
we secured more than $20 million in<br />
funding for commercially-sponsored<br />
clinical trials by leading pharmaceutical<br />
and biotechnology companies.<br />
Leadership is a key component of<br />
driving outstanding research, leading<br />
to excellent patient outcomes.<br />
Research leadership is supported by<br />
Professor Erwin Loh, as the Executive<br />
Director for Research and Professor Bill<br />
Sievert, Clinical Research Director and<br />
the Monash Health Research Council,<br />
who represent research across Monash<br />
Health and our partners.<br />
Monash Health is also a major partner<br />
in the Monash Partners Academic<br />
Health Science Centre (MPAHSC), a<br />
group of eight independent, worldclass<br />
providers of health services,<br />
research and education in Melbourne’s<br />
south east. We were pleased to lead<br />
an application to the NHMRC for this<br />
centre to be recognised as one of a<br />
limited number of national Academic<br />
Science Centres. Our research is<br />
reliant on the participation of patients,<br />
volunteers and carers, who dedicate<br />
their time for the benefit of future<br />
healthcare outcomes. We are very<br />
grateful for their contribution. We<br />
would like to thank all of the patients,<br />
volunteers and carers who partner<br />
with us and look forward to our work<br />
contributing to better outcomes for<br />
all. We could not be prouder of our<br />
clinicians and researchers and their<br />
wonderful work of discovery and<br />
innovation.<br />
Andrew Stripp<br />
Chief Executive, Monash Health<br />
Barbara Yeoh, AM<br />
Chair, Board of Directors<br />
06